Since we demonstrated the effects of CNTNAP4 deficiency in SNpc DA neurons on DA neuronal activity, α-synuclein expression, and dopaminergic synaptic transmission, we next examined whether CNTNAP4 concentrations are altered in human patients with PD. This evidence concerns the gene CNTNAP4 and Parkinson disease.